myeloid neoplasm
myeloid neoplasm
Explore linked clinical trials. Standard reference: MONDO:000517024 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT06129734 | |
| An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies | myeloid neoplasm | Recruiting | Phase 1 | 2026-09-28 | NCT07619287 | |
| Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute leukemia of ambiguous lineage, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Not applicable | 2026-09-17 | NCT07094750 | |
| A Telehealth Advance Care Planning Intervention | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myelodysplastic/myeloproliferative neoplasm, myeloid leukemia, myeloid neoplasm, neoplasm, primary myelofibrosis | Recruiting | Not applicable | 2026-09-11 | NCT05875805 | |
| A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-08-20 | NCT05796570 | |
| Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, myeloid neoplasm, neoplasm, viral infectious disease | Recruiting | Not applicable | 2026-08-19 | NCT06710418 | |
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | Chronic Disease, Disease Attributes, Eosinophilia, Hemic and Lymphatic Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acquired polycythemia vera, acute myeloid leukemia, atypical chronic myeloid leukemia, BCR-ABL1 negative, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cellular phase chronic idiopathic myelofibrosis, chronic myelomonocytic leukemia, chronic neutrophilic leukemia, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, hypereosinophilic syndrome, leukemia, leukocyte disorder, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, myeloid neoplasm, myeloproliferative neoplasm, myeloproliferative neoplasm, unclassifiable, neoplasm, primary myelofibrosis, thrombocytosis disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-16 | NCT03862157 | |
| A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms | cancer, myeloid neoplasm, neoplasm | Recruiting | Not applicable | 2026-07-15 | NCT04981821 | |
| HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Phase 1 | 2026-07-14 | NCT06594445 | |
| Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories | myeloid neoplasm | Recruiting | Not applicable | 2026-07-06 | NCT07263074 | |
| Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, juvenile myelomonocytic leukemia, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, myeloid neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-06-25 | NCT05656248 | |
| Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-04-29 | NCT04501120 | |
| Germline Testing for Predisposition to Myeloid Malignancies | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease susceptibility, inherited disease susceptibility, myeloid neoplasm | Recruiting | Not applicable | 2026-04-24 | NCT07112287 | |
| Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, acute biphenotypic leukemia, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, myeloid leukemia, myeloid neoplasm, myeloid sarcoma, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-04-17 | NCT04797767 | |
| Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, bone marrow disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Phase 1 | 2026-03-04 | NCT07044544 | |
| Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant | myeloid neoplasm | Recruiting | Phase 2 | 2026-02-24 | NCT03850418 | |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Neoplasms by Site, bone marrow disorder, clonal hematopoiesis of indeterminate potential, hematologic disorder, hematopoietic and lymphoid system neoplasm, hereditary disease, hereditary neoplastic syndrome, myeloid neoplasm, neoplasm | Recruiting | Not applicable | 2026-02-23 | NCT02958462 | |
| Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, myeloproliferative neoplasm, neoplasm, primary myelofibrosis | Active, not recruiting | Phase 1 | 2026-01-28 | NCT05455294 | |
| Two Step Haplo With Radiation Conditioning | B-cell chronic lymphocytic leukemia, Blood Protein Disorders, Bone Marrow Failure Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, acquired polycythemia vera, acute myeloid leukemia, adult T-cell leukemia/lymphoma, anemia, aplastic anemia, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cardiovascular disorder, chronic myelomonocytic leukemia, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, myeloid neoplasm, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, primary myelofibrosis, thrombocytosis disease, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2025-10-30 | NCT05031897 | |
| Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, myeloid neoplasm, neoplasm | Recruiting | Phase 2 | 2025-09-16 | NCT06621212 | |
| A Study of GLB-001 in Patients With Myeloid Malignancies | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, acquired polycythemia vera, acute myeloid leukemia, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, neoplasm, primary myelofibrosis, thrombocytosis disease | Recruiting | Phase 1 | 2025-08-19 | NCT06378437 | |
| A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies | myeloid neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-06-08 | NCT07011186 | |
| The Myeloid Neoplasms Biology and Outcome Project | myeloid neoplasm | Recruiting | Not stated | 2025-03-25 | NCT05074316 | |
| Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients | myeloid neoplasm | Not yet recruiting | Not stated | 2024-08-06 | NCT06090513 |